295 related articles for article (PubMed ID: 12004055)
1. Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rate.
Li JG; Chen C; Liu-Chen LY
J Biol Chem; 2002 Jul; 277(30):27545-52. PubMed ID: 12004055
[TBL] [Abstract][Full Text] [Related]
2. kappa Opioid receptor interacts with Na(+)/H(+)-exchanger regulatory factor-1/Ezrin-radixin-moesin-binding phosphoprotein-50 (NHERF-1/EBP50) to stimulate Na(+)/H(+) exchange independent of G(i)/G(o) proteins.
Huang P; Steplock D; Weinman EJ; Hall RA; Ding Z; Li J; Wang Y; Liu-Chen LY
J Biol Chem; 2004 Jun; 279(24):25002-9. PubMed ID: 15070904
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells.
Li J; Li JG; Chen C; Zhang F; Liu-Chen LY
Mol Pharmacol; 2002 Jan; 61(1):73-84. PubMed ID: 11752208
[TBL] [Abstract][Full Text] [Related]
4. (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation.
Zhang F; Li J; Li JG; Liu-Chen LY
J Pharmacol Exp Ther; 2002 Sep; 302(3):1184-92. PubMed ID: 12183679
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG; Zhang F; Jin XL; Liu-Chen LY
J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation.
Li JG; Benovic JL; Liu-Chen LY
Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950
[TBL] [Abstract][Full Text] [Related]
7. Localization of the kappa opioid receptor in lipid rafts.
Xu W; Yoon SI; Huang P; Wang Y; Chen C; Chong PL; Liu-Chen LY
J Pharmacol Exp Ther; 2006 Jun; 317(3):1295-306. PubMed ID: 16505160
[TBL] [Abstract][Full Text] [Related]
8. GEC1 interacts with the kappa opioid receptor and enhances expression of the receptor.
Chen C; Li JG; Chen Y; Huang P; Wang Y; Liu-Chen LY
J Biol Chem; 2006 Mar; 281(12):7983-93. PubMed ID: 16431922
[TBL] [Abstract][Full Text] [Related]
9. Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family.
Reczek D; Berryman M; Bretscher A
J Cell Biol; 1997 Oct; 139(1):169-79. PubMed ID: 9314537
[TBL] [Abstract][Full Text] [Related]
10. Agonist-promoted Lys63-linked polyubiquitination of the human kappa-opioid receptor is involved in receptor down-regulation.
Li JG; Haines DS; Liu-Chen LY
Mol Pharmacol; 2008 Apr; 73(4):1319-30. PubMed ID: 18212250
[TBL] [Abstract][Full Text] [Related]
11. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation.
Li JG; Luo LY; Krupnick JG; Benovic JL; Liu-Chen LY
J Biol Chem; 1999 Apr; 274(17):12087-94. PubMed ID: 10207034
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation.
Wang Y; Li JG; Huang P; Xu W; Liu-Chen LY
J Pharmacol Exp Ther; 2003 Dec; 307(3):1127-34. PubMed ID: 14557376
[TBL] [Abstract][Full Text] [Related]
13. Agonist-induced desensitization and down-regulation of the human kappa opioid receptor expressed in Chinese hamster ovary cells.
Zhu J; Luo LY; Mao GF; Ashby B; Liu-Chen LY
J Pharmacol Exp Ther; 1998 Apr; 285(1):28-36. PubMed ID: 9535991
[TBL] [Abstract][Full Text] [Related]
14. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway.
Li JG; Chen C; Liu-Chen LY
Biochemistry; 2007 Sep; 46(38):10960-70. PubMed ID: 17711303
[TBL] [Abstract][Full Text] [Related]
15. Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia.
Morales FC; Takahashi Y; Kreimann EL; Georgescu MM
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17705-10. PubMed ID: 15591354
[TBL] [Abstract][Full Text] [Related]
16. Type I PDZ ligands are sufficient to promote rapid recycling of G Protein-coupled receptors independent of binding to N-ethylmaleimide-sensitive factor.
Gage RM; Matveeva EA; Whiteheart SW; von Zastrow M
J Biol Chem; 2005 Feb; 280(5):3305-13. PubMed ID: 15548537
[TBL] [Abstract][Full Text] [Related]
17. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
18. Distinct cell type-specific expression of scaffolding proteins EBP50 and E3KARP: EBP50 is generally expressed with ezrin in specific epithelia, whereas E3KARP is not.
Ingraffea J; Reczek D; Bretscher A
Eur J Cell Biol; 2002 Feb; 81(2):61-8. PubMed ID: 11893083
[TBL] [Abstract][Full Text] [Related]
19. Oligomerization of NHERF-1 and NHERF-2 PDZ domains: differential regulation by association with receptor carboxyl-termini and by phosphorylation.
Lau AG; Hall RA
Biochemistry; 2001 Jul; 40(29):8572-80. PubMed ID: 11456497
[TBL] [Abstract][Full Text] [Related]
20. The NHE1 Na+/H+ exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival.
Wu KL; Khan S; Lakhe-Reddy S; Jarad G; Mukherjee A; Obejero-Paz CA; Konieczkowski M; Sedor JR; Schelling JR
J Biol Chem; 2004 Jun; 279(25):26280-6. PubMed ID: 15096511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
